Adicet Bio (ACET)
(Delayed Data from NSDQ)
$0.67 USD
-0.02 (-2.19%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $0.66 -0.01 (-1.58%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Adicet Bio, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
ACET 0.67 -0.02(-2.19%)
Will ACET be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ACET based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ACET
Adicet Bio (ACET) Upgraded to Buy: Here's What You Should Know
ACET: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for ACET
Adicet Bio (ACET) Advances Phase 1 Trial for Autoimmune Treatment | ACET Stock News
Adicet Bio doses first patient in second cohort of ADI-001 trial
Adicet Bio Announces First Systemic Sclerosis (SSc) Patient Dosed in Ongoing Phase 1 Clinical ...
Adicet Bio (ACET) Receives Buy Rating from HC Wainwright & Co. | ACET Stock News
ACET Stock Potential Boosted by New Analyst Coverage | ACET Stock News